Alterity Therapeutics Limited
ATH
Classement en actions
#25702
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Prix de l'action
$0.20453259
Capitalisation boursière
$44.69M
Changement (1 jour)
1.75%
Changement (1 an)
-41.56%
Pays
AU
Échange Alterity Therapeutics Limited (ATH)
Catégorie
Healthcare
Capitalisation boursière de Alterity Therapeutics Limited(ATH)
Capitalisation boursière: $44.69M
En October 2026, Alterity Therapeutics Limited a une capitalisation boursière de $44.69M. Cela fait de Alterity Therapeutics Limited la 25702nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Alterity Therapeutics Limited du 2012 au 2026
ATH par rapport au top 5 des plus populaires stocks
| Prix pour ATH | L’actif B | La capitalisation boursière de B | Résultats | |
|---|---|---|---|---|
|
$23,647.74
$54.63M
|
$5.167T | +9,458,994.12% | ||
|
$22,950.89
$54.63M
|
$5.015T | +9,180,256.27% | ||
|
$18,802.72
$54.63M
|
$4.108T | +7,520,988.16% | ||
|
$17,857.65
$54.63M
|
$3.902T | +7,142,959.64% | ||
|
$12,308.70
$54.63M
|
$2.689T | +4,923,379.95% |